1.Thompson, WW, Comanor, L and Shay, DK (2006) Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. Journal of Infectious Diseases 194, (suppl. 2), S82–S91.
2.Neuzil, KM et al. (2003) Winter respiratory viruses and health care use: a population-based study in the northwest United States. Clinical Infectious Diseases 37, 2011–2017.
3.Gilca, R et al. (2014) Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season. Open Forum Infectious Diseases 1, ofu086.
4.Fowlkes, A et al. (2014) Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010–2011. Journal of Infectious Diseases 209, 1715–1725.
5.Rolfes, MA et al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Available at https://www.cdc.gov/flu/about/disease/2015-16.htm. Published 2016. (Accessed 2 February 2017).
6.Puig-Barberà, J et al. (2014) First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season. BMC Public Health 14, 564.
7.Louie, JK et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302, 1896.
8.Jain, S et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009. New England Journal of Medicine 361, 1935–1944.
9.Díaz, E et al. (2011) Impact of obesity in patients infected with 2009 influenza A(H1N1). Chest 139, 382–386.
10.Morgan, OW et al. (2010) Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 5, e9694.
11.Bolotin, S et al. (2012) A New sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period. PLoS ONE 7, e30279.
12.Martin-Loeches, I et al. (2011) Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Journal of Critical Care 15, R286.
13.Viasus, D et al. (2012) Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season. Clinical Microbiology and Infection 18, E55–E62.
14.Appiah, GD et al. (2017) Increased antiviral treatment among hospitalized children and adults with laboratory-confirmed influenza, 2010–2015. Clinical Infectious Diseases 64, 364–367.
15.Petrie, JG et al. (2016) Influenza vaccine effectiveness against antigenically drifted influenza higher than expected in hospitalized adults: 2014–2015. Clinical Infectious Diseases 63, 1017–1025.
16.Romero-Ortuno, R et al. (2010) A frailty instrument for primary care: findings from the survey of health, ageing and retirement in Europe (SHARE). BMC Geriatrics 10, 57.
17.Reuben, DB et al. (1992) Value of functional status as a predictor of mortality: results of a prospective study. The American Journal of Medicine 93, 663–669.
18.Shih, SL et al. (2015) Functional status outperforms comorbidities in predicting acute care readmissions in medically complex patients. Journal of General Internal Medicine 30, 1688–1695.
19.Andrew, MK et al. (2017) The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people. Journal of Infectious Diseases 216, 405–414.
20.Librero, J, Peiró, S and Ordiñana, R (1999) Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. Journal of Clinical Epidemiology 52, 171–179.
21.Lee, N et al. (2010) Outcomes of adults hospitalised with severe influenza. Thorax 65, 510–515.
22.Louie, JK et al. (2012) Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clinical Infectious Diseases 55, 1198–1204.
23.Muthuri, SG et al. (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. The Lancet Respiratory Medicine 2, 395–404.
24.McGeer, A et al. (2007) Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clinical Infectious Diseases 45, 1568–1575.
25.Appiah, GD et al. (2015) Influenza activity – United States, 2014–15 season and composition of the 2015–16 influenza vaccine. Morbidity and Mortality Weekly Report 64, 583–590. http://www.ncbi.nlm.nih.gov/pubmed/26042650 (Accessed 21 July 2016).
26.Flannery, B et al. (2016) Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014–2015. Journal of Infectious Diseases 214, 1010–1019.
27.Puig-Barberà, J et al. (2015) Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Euro Surveillance 20, 1–6. Available at http://www.eurosurveillance.org:pii=21044 (Accessed 19 July 2016).
28.Deiss, RG et al. (2015) Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease. Vaccine 33, 7160–7167.
29.VanWormer, JJ et al. (2014) A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting. BMC Infectious Diseases 14, 231.
30.Arriola, CS et al. (2015) Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012–2013 season in the United States. Journal of Infectious Diseases 212, 1200–1208.
31.Casado, I et al. (2016) Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Review of Vaccines 15, 425–432.
32.Yu, H et al. (2011) Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clinical Infectious Diseases 52, 457–465.
33.Harper, SA et al. (2009) Seasonal influenza in adults and children—diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases 48, 1003–1032.
34.Fiore, AE et al. (2011) Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 60:1–24.